Correlation Between Altamira Therapeutics and Avenue Therapeutics
Can any of the company-specific risk be diversified away by investing in both Altamira Therapeutics and Avenue Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Altamira Therapeutics and Avenue Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Altamira Therapeutics and Avenue Therapeutics, you can compare the effects of market volatilities on Altamira Therapeutics and Avenue Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Altamira Therapeutics with a short position of Avenue Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Altamira Therapeutics and Avenue Therapeutics.
Diversification Opportunities for Altamira Therapeutics and Avenue Therapeutics
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Altamira and Avenue is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Altamira Therapeutics and Avenue Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avenue Therapeutics and Altamira Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Altamira Therapeutics are associated (or correlated) with Avenue Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avenue Therapeutics has no effect on the direction of Altamira Therapeutics i.e., Altamira Therapeutics and Avenue Therapeutics go up and down completely randomly.
Pair Corralation between Altamira Therapeutics and Avenue Therapeutics
Given the investment horizon of 90 days Altamira Therapeutics is expected to under-perform the Avenue Therapeutics. In addition to that, Altamira Therapeutics is 1.41 times more volatile than Avenue Therapeutics. It trades about -0.19 of its total potential returns per unit of risk. Avenue Therapeutics is currently generating about -0.22 per unit of volatility. If you would invest 245.00 in Avenue Therapeutics on August 30, 2024 and sell it today you would lose (39.00) from holding Avenue Therapeutics or give up 15.92% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Altamira Therapeutics vs. Avenue Therapeutics
Performance |
| Timeline |
| Altamira Therapeutics |
| Avenue Therapeutics |
Altamira Therapeutics and Avenue Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Altamira Therapeutics and Avenue Therapeutics
The main advantage of trading using opposite Altamira Therapeutics and Avenue Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Altamira Therapeutics position performs unexpectedly, Avenue Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avenue Therapeutics will offset losses from the drop in Avenue Therapeutics' long position.| Altamira Therapeutics vs. Pyxis Oncology | Altamira Therapeutics vs. Zura Bio Limited | Altamira Therapeutics vs. Elevation Oncology | Altamira Therapeutics vs. Immix Biopharma |
| Avenue Therapeutics vs. Hoth Therapeutics | Avenue Therapeutics vs. Revelation Biosciences | Avenue Therapeutics vs. Neurobo Pharmaceuticals | Avenue Therapeutics vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |